SMi's 2nd Annual Next Generation Pharmaceutical Cleanroom
SMi Group are pleased to announce the 2nd Annual Next Generation Pharmaceutical Cleanroom Conference. An event that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.
This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals, biologicals, and cleanroom industry experts to explore hot topics within cleanroom design and engineering, best practices and regulation, environmental and contamination control, and pharmaceutical microbiology.
In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals, technological advancements in cleanrooms, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market.
This event will look in-depth at the significant change that the cleanroom industry is going through. From the new operating practices that keep the product as sterile as possible, to the developments in technology that are enabling this to happen. Whether through robotics, automated disinfection, or data driven environmental monitoring- this conference will highlight the developments that are fundamentally changing the industry.
HIGHLIGHTS FOR 2020:
- Gain insight into the revised regulations and new standards, from EN 17141 to EU Annex 1 GMP
- Examine the changes to Annex 1 and strategies of Environmental Monitoring Program implementation with Sanofi and Merck
- Explore the challenges of creating cleanrooms fit for purpose and qualifying automated filling lines
- Uncover the effective risk-based approaches in cleanroom verification and cleaning monitoring
- Discuss the advantages of robotics in cleanrooms and the automated cleanroom of the future
- Join the in-depth panel on the latest regulatory standards and the impact of the pandemic on the industry